GOLDSHIELD HOSPITAL EUROPE *** Antigen Pharmaceuticals *** Goldshield Pharmaceuticals *** Goldshield Oncology *** GOLDSHIELD HOSPITAL EUROPE *** Antigen Pharmaceuticals *** Goldshield Pharmaceuticals *** Goldshield Oncology *** GOLDSHIELD HOSPITAL EUROPE *** Antigen Pharmaceuticals *** Goldshield Pharmaceuticals *** Goldshield Oncology     About       ● Antigen Pharmaceuticals ●   Bupivacaine ●   Bufentil ●   Robinul ●   Dopram ●   Pitressin ●   AutoDetect ●   Noseeze ●   Remodulin Vision     ●   AutoDetect ●   Noseeze ●   Remodulin ●   Amsidine Products     ●   Antigen Pharmaceuticals ●   Goldshield Hospital ●   Goldshield Oncology News     ●   Remodulin for Pulmonary Arterial Hypertension ●   AutoDetect Syringe - An Advance in Epidural and Laparoscopic Procedures ●   Noseeze Marketing Rights for EU ●   Non-Availability of Products (May 2005) ●   Autodetect - A Spring Loaded Syringe for Epidural Procedures (Nov 2005) Links   ●   Our parent company, Goldshield PLC ●   UK Department of Health ●   The Royal College of Anaesthetists ●   The Association of Anaesthetists of Great Britain and Ireland ●   The UK Pulmonary Hypertension Association ●   National Library of Medicine, USA ●   United Therapeutics Inc ●   Indigo Orb Inc ●   MHRA ●   Irish Medicine Board ●   MIMS ●   Chemist & Druggist ●   British National Formulary ●   The Pharmaceutical Journal ●   NHS Gateway ●   ENT Technologies Contact     ●   hospitalEU@goldshieldplc.com ●   autodetect@goldshieldplc.com ●   oncology@goldshieldplc.com ●   noseeze@goldshieldplc.com ●   remodulin@goldshieldplc.com ●   medicalinfo@goldshieldplc.com   Copyrights Reserved Goldshield Hospital Europe 2006-2007